Safety and efficacy of micropulse in pediatric eyes with refractory glaucoma

Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design: Hospital-based prospective interventional study. Methods: Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and Ma...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of ophthalmology Vol. 73; no. Suppl 2; pp. S227 - S231
Main Authors Sivasubramanian, Raajaraajeshwari, Siddharth, Kumar, Senthilkumar, Vijayalakshmi A, Mani, Iswarya, Rajendrababu, Sharmila
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer - Medknow 01.03.2025
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer Medknow Publications
Edition2
Subjects
Adolescent
Care and treatment
Child
Child, Preschool
childhood glaucoma
Ciliary Body - surgery
Development and progression
Eye
Female
Follow-Up Studies
Glaucoma
Glaucoma - physiopathology
Glaucoma - surgery
Glaucoma in children
Humans
Infant
Intraocular Pressure - physiology
Laser Coagulation - methods
Light coagulation
Male
Medical care
Methods
micropulse transscleral cyclophotocoagulation
Original
Original Article
Patient outcomes
Patients
pediatric glaucoma
Pediatrics
Prospective Studies
Quality management
refractory glaucoma
Sclera - surgery
Success
Surgery
Tonometry, Ocular
Treatment Outcome
Visual Acuity
India
Childhood glaucoma
micropulse transscleral cyclophotocoagulation
pediatric glaucoma
refractory glaucoma
Online AccessGet full text
ISSN0301-4738
1998-3689
1998-3689
DOI10.4103/IJO.IJO_1066_24

Cover

Abstract Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design: Hospital-based prospective interventional study. Methods: Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up. Results: A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study. Conclusion: MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
AbstractList Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design: Hospital-based prospective interventional study. Methods: Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up. Results: A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study. Conclusion: MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
Purpose:To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma.Design:Hospital-based prospective interventional study.Methods:Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up.Results:A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study.Conclusion:MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma.PURPOSETo analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma.Hospital-based prospective interventional study.DESIGNHospital-based prospective interventional study.Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up.METHODSPatients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up.A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study.RESULTSA total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study.MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.CONCLUSIONMP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Hospital-based prospective interventional study. A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study. MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Hospital-based prospective interventional study. Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up. A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study. MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction.
Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design: Hospital-based prospective interventional study. Methods: Patients less than 18 years of age, receiving MP-TSCPC between December 1, 2022 and May 31, 2023 with at least three follow-ups within 6 months period, were included in the study. Post-laser evaluation was done at day 1, 1 month, 3 months, and 6 months. Success outcomes were calculated at 1, 3, and 6 months follow-up. Results: A total of 23 eyes of 23 patients were included in the study. Mean intraocular pressure (IOP) lowering agents (P = 0.041) had significant change compared to the baseline value; however, the change was insignificant when eyes requiring additional IOP-lowering surgeries during the follow-up period were excluded. There was a significant reduction in IOP at each follow-up visit compared to the baseline (P = 0.000014). Two (8.6%) eyes required additional intervention within 1-month follow-up, another six eyes (26%) between 1-3 months, and three eyes (13%) between 3-6 months of MP-TSCPC. Total success was highest at 56.5% (13 eyes) at 1-month follow-up and at least 34.7% (8 eyes) at 6-month follow-up. No major complications were reported in our study. Conclusion: MP-TSCPC was found to be safe and effective in pediatric population. However, we observed a gradual reduction in the success with time, and thus, it can be individualized to patients with high risk for incisional surgery or those requiring immediate IOP reduction. Keywords: Childhood glaucoma, micropulse transscleral cyclophotocoagulation, pediatric glaucoma, refractory glaucoma
Audience Professional
Author Siddharth, Kumar
Sivasubramanian, Raajaraajeshwari
Rajendrababu, Sharmila
Senthilkumar, Vijayalakshmi A
Mani, Iswarya
AuthorAffiliation Department of General Ophthalmology, Aravind Eye Hospital, Madurai, Tamil Nadu, India
1 Department of Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India
2 Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India
3 Department of Biostatistics, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India
AuthorAffiliation_xml – name: 1 Department of Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India
– name: 3 Department of Biostatistics, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India
– name: Department of General Ophthalmology, Aravind Eye Hospital, Madurai, Tamil Nadu, India
– name: 2 Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India
Author_xml – sequence: 1
  givenname: Raajaraajeshwari
  surname: Sivasubramanian
  fullname: Sivasubramanian, Raajaraajeshwari
– sequence: 2
  givenname: Kumar
  surname: Siddharth
  fullname: Siddharth, Kumar
– sequence: 3
  givenname: Vijayalakshmi A
  surname: Senthilkumar
  fullname: Senthilkumar, Vijayalakshmi A
– sequence: 4
  givenname: Iswarya
  surname: Mani
  fullname: Mani, Iswarya
– sequence: 5
  givenname: Sharmila
  surname: Rajendrababu
  fullname: Rajendrababu, Sharmila
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39982084$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9v0zAUxyM0xLrBmRuKxIVLOv-IE-eEpokfRUU7DM6Wa79k7lK7OAlV_nteyTa1qCiyItmf983L8-ciOfPBQ5K8pWSeU8KvFt9u57gUJUWhWP4imdGqkhkvZHWWzAgnNMtLLs-Ti65bE8JLWslXyTlHiBGZz5Llna6hH1PtbQp17Yw2YxrqdONMDNuh7SB1Pt2CdbqPzqQwQpfuXH-fRqijNn2IY9q0ejBho18nL2uNJW8e35fJz8-fftx8zZa3XxY318vMiLwcs5IV5UqsakatFYYYqAA7hUILWuXUSKCMQQHYI1hZC1MakKzOBeBZpUvGL5PFlGuDXqttdBsdRxW0U383QmyUjr0zLShRrEglgFspeE6FlMJaXhS0pNSWuQTM-jhlbYfVBqwB30fdHoUen3h3r5rwW1FGKOdEYsKHx4QYfg3Q9WrjOgNtqz2EoVOcFhWVjEmO6Pt_0HUYosdZTRSlRBxQjcY_cL4O-GGzD1XXEmNIWUiKVHaCasADdomW1A63j_j5CR4fC3jZJwveHU7meSRP8iBwNQGoStehD88IJWqvp9qreaAnVnyfKnah7SF2D-2wg6gw_cGH3f_K1B1jpZpEVSiqehKV_wGUnu_a
Cites_doi 10.1111/aos.14661
10.3928/0191-3913-19970701-11
10.1111/j.1442-9071.2010.02238.x
10.1001/jamaophthalmol.2015.1856
10.4103/ijo.IJO_1289_22
10.1007/s10792-021-01697-1
10.1111/ceo.12360
10.3928/1542-8877-19950901-05
10.1177/1120672119858226
10.5005/jp-journals-10008-1192
10.1007/s40123-022-00598-5
10.1038/eye.1998.90
10.1007/s10103-015-1856-9
10.1016/j.ajo.2011.10.024
10.1097/IJG.0000000000001053
10.1177/1120672118805872
10.1016/0002-9394(83)90260-X
10.1016/S0161-6420(98)91042-9
10.1016/j.ajo.2005.03.057
10.1159/000073068
10.1007/s10792-021-02023-5
10.1097/IJG.0000000000000757
10.1186/s12886-024-03358-0
10.1067/mpa.2001.116868
10.1371/journal.pone.0291247
10.1097/ICU.0000000000000642
10.1016/S0161-6420(01)00898-3
10.1097/ICU.0000000000000516
10.1016/j.jaapos.2006.08.015
10.1097/IJG.0000000000002335
10.1016/j.ophtha.2015.07.028
10.1159/000458495
10.1016/j.jaapos.2014.08.003
ContentType Journal Article
Copyright 2025 Indian Journal of Ophthalmology
Copyright © 2025 Indian Journal of Ophthalmology.
COPYRIGHT 2025 Medknow Publications and Media Pvt. Ltd.
2025. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright: © 2025 Indian Journal of Ophthalmology 2025
Copyright_xml – notice: 2025 Indian Journal of Ophthalmology
– notice: Copyright © 2025 Indian Journal of Ophthalmology.
– notice: COPYRIGHT 2025 Medknow Publications and Media Pvt. Ltd.
– notice: 2025. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright: © 2025 Indian Journal of Ophthalmology 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
5PM
DOA
DOI 10.4103/IJO.IJO_1066_24
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1998-3689
Edition 2
EndPage S231
ExternalDocumentID oai_doaj_org_article_56b095e3d853415885dd3661711d748e
PMC12013308
A828307681
39982084
10_4103_IJO_IJO_1066_24
IJOP-73-S227
Genre Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
.55
29I
2WC
36B
53G
5GY
5VS
7X7
88E
8FI
8FJ
8G5
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C1A
CCPQU
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBS
EJD
EMB
EMK
EMOBN
EOJEC
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HMCUK
HYE
IAO
IEA
IHE
IHR
IL9
INH
INR
IOF
IPNFZ
IPO
ITC
KQ8
M1P
M2O
M48
O5R
O5S
OBODZ
OK1
OVD
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PMFND
PQQKQ
PROAC
PSQYO
RIG
RMW
RNS
RPM
SV3
TEORI
TR2
TUS
UKHRP
W3E
X7M
XSB
ZXP
AAYXX
ADJBI
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c547y-7267b5bf21dd5c0ce9e030e6a51941c8e122e6e998ed8f5c7ce82f45e1c89a723
IEDL.DBID M48
ISSN 0301-4738
1998-3689
IngestDate Wed Aug 27 01:32:50 EDT 2025
Thu Aug 21 18:26:58 EDT 2025
Fri Sep 05 09:04:06 EDT 2025
Mon Jun 30 12:40:41 EDT 2025
Tue Jun 17 21:57:23 EDT 2025
Thu Jun 12 23:57:34 EDT 2025
Tue Jun 10 20:57:00 EDT 2025
Sat May 10 01:40:25 EDT 2025
Tue Jul 01 05:28:53 EDT 2025
Wed May 28 23:00:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 2
Keywords Childhood glaucoma
micropulse transscleral cyclophotocoagulation
pediatric glaucoma
refractory glaucoma
Language English
License Copyright © 2025 Indian Journal of Ophthalmology.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c547y-7267b5bf21dd5c0ce9e030e6a51941c8e122e6e998ed8f5c7ce82f45e1c89a723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4103/IJO.IJO_1066_24
PMID 39982084
PQID 3169111053
PQPubID 226508
ParticipantIDs doaj_primary_oai_doaj_org_article_56b095e3d853415885dd3661711d748e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12013308
proquest_miscellaneous_3169182283
proquest_journals_3169111053
gale_infotracmisc_A828307681
gale_infotracgeneralonefile_A828307681
gale_infotracacademiconefile_A828307681
pubmed_primary_39982084
crossref_primary_10_4103_IJO_IJO_1066_24
wolterskluwer_medknow_10_4103_IJO_IJO_1066_24_S227_Safety_and_efficacy
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20250300
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: 20250300
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
– name: Mumbai
PublicationTitle Indian journal of ophthalmology
PublicationTitleAlternate Indian J Ophthalmol
PublicationYear 2025
Publisher Wolters Kluwer - Medknow
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer Medknow Publications
Publisher_xml – name: Wolters Kluwer - Medknow
– name: Medknow Publications and Media Pvt. Ltd
– name: Medknow Publications & Media Pvt. Ltd
– name: Wolters Kluwer Medknow Publications
References Kuciel-Polczak (R27-20250221) 2023; 12
Vega-Garces (R34-20250221) 2024; 33
Souissi (R14-20250221) 2021; 99
Wang (R33-20250221) 2024; 19
Hassanein (R5-20250221) 2020; 30
Balbaid (R29-20250221) 2024; 24
Tai (R9-20250221) 2014; 18
Carter (R18-20250221) 2007; 11
Phelan (R12-20250221) 1995; 26
Neely (R17-20250221) 2001; 5
Autrata (R13-20250221) 2003; 217
Bock (R16-20250221) 1997; 34
Abdelrahman (R26-20250221) 2018; 27
Jabs (R24-20250221) 2005; 140
Tan (R20-20250221) 2010; 38
Aquino (R22-20250221) 2015; 43
Hamard (R32-20250221) 2000; 23
Kuchar (R19-20250221) 2016; 31
Cunliffe (R10-20250221) 1998; 12
Elhefney (R25-20250221) 2020; 30
Wagle (R11-20250221) 1998; 105
Kirwan (R15-20250221) 2002; 109
Lee (R28-20250221) 2017; 26
Yu (R2-20250221) 2015; 9
Malik (R3-20250221) 2020; 31
Fili (R21-20250221) 2022; 42
Ariga (R30-20250221) 2021; 41
Chang (R1-20250221) 2017; 59
Chen (R8-20250221) 2015; 133
Thau (R4-20250221) 2018; 29
McPherson (R6-20250221) 1983; 95
Gedde (R23-20250221) 2012; 153
Jayaram (R7-20250221) 2015; 122
Rajendrababu (R31-20250221) 2023; 71
References_xml – volume: 99
  start-page: e621
  year: 2021
  ident: R14-20250221
  article-title: An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.14661
– volume: 34
  start-page: 235
  year: 1997
  ident: R16-20250221
  article-title: Transscleral diode laser cyclophotocoagulation for refractory pediatric glaucomas
  publication-title: J Pediatr Ophthalmol Strabismus
  doi: 10.3928/0191-3913-19970701-11
– volume: 38
  start-page: 266
  year: 2010
  ident: R20-20250221
  article-title: Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/j.1442-9071.2010.02238.x
– volume: 133
  start-page: 1030
  year: 2015
  ident: R8-20250221
  article-title: Valved glaucoma drainage devices in pediatric glaucoma: Retrospective long-term outcomes
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2015.1856
– volume: 71
  start-page: 140
  year: 2023
  ident: R31-20250221
  article-title: Short-term outcomes of micropulse transscleral cyclophotocoagulation as a primary versus additional therapy in eyes with uncontrolled glaucoma
  publication-title: Indian J Ophthalmol
  doi: 10.4103/ijo.IJO_1289_22
– volume: 41
  start-page: 2639
  year: 2021
  ident: R30-20250221
  article-title: Micropulse trans-scleral diode laser cyclophotocoagulation in refractory glaucoma: an initial experience in Indian eyes
  publication-title: Int Ophthalmol
  doi: 10.1007/s10792-021-01697-1
– volume: 43
  start-page: 40
  year: 2015
  ident: R22-20250221
  article-title: Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: A randomized exploratory study
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/ceo.12360
– volume: 26
  start-page: 401
  year: 1995
  ident: R12-20250221
  article-title: Contact transscleral Nd:YAG laser cyclophotocoagulation for the treatment of refractory pediatric glaucoma
  publication-title: Ophthalmic Surg Lasers
  doi: 10.3928/1542-8877-19950901-05
– volume: 30
  start-page: 1149
  year: 2020
  ident: R25-20250221
  article-title: Micropulsed diode laser cyclophotocoagulation in recurrent pediatric glaucoma
  publication-title: Eur J Ophthalmol
  doi: 10.1177/1120672119858226
– volume: 9
  start-page: 92
  year: 2015
  ident: R2-20250221
  article-title: Review on the management of primary congenital glaucoma
  publication-title: J Curr Glaucoma Pract
  doi: 10.5005/jp-journals-10008-1192
– volume: 12
  start-page: 179
  year: 2023
  ident: R27-20250221
  article-title: Assessment of the effectiveness of glaucoma treatment using micropulse transscleral cyclophotocoagulation in patients with glaucoma who have previously undergone vitreoretinal surgery
  publication-title: Ophthalmol Ther
  doi: 10.1007/s40123-022-00598-5
– volume: 12
  start-page: 379
  year: 1998
  ident: R10-20250221
  article-title: Long-term follow-up of Molteno drains used in the treatment of glaucoma presenting in childhood
  publication-title: Eye (Lond)
  doi: 10.1038/eye.1998.90
– volume: 31
  start-page: 393
  year: 2016
  ident: R19-20250221
  article-title: Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma
  publication-title: Lasers Med Sci
  doi: 10.1007/s10103-015-1856-9
– volume: 153
  start-page: 804
  year: 2012
  ident: R23-20250221
  article-title: Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.10.024
– volume: 27
  start-page: 900
  year: 2018
  ident: R26-20250221
  article-title: Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000001053
– volume: 30
  start-page: 162
  year: 2020
  ident: R5-20250221
  article-title: Factors associated with early and late failure after goniotomy for primary pediatric glaucoma
  publication-title: Eur J Ophthalmol
  doi: 10.1177/1120672118805872
– volume: 23
  start-page: 773
  year: 2000
  ident: R32-20250221
  article-title: La cyclophotocoagulation transsclérale au laser diode dans le traitement des glaucomes réfractaires du sujet jeune [Trans-scleral diode laser cyclophotocoagulation for the treatment of refractory pediatric glaucoma]
  publication-title: J Fr Ophtalmol
– volume: 95
  start-page: 427
  year: 1983
  ident: R6-20250221
  article-title: Goniotomy vs external trabeculotomy for developmental glaucoma
  publication-title: Am J Ophthalmol
  doi: 10.1016/0002-9394(83)90260-X
– volume: 105
  start-page: 1921
  year: 1998
  ident: R11-20250221
  article-title: Long-term outcome of cyclocryotherapy for refractory pediatric glaucoma
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(98)91042-9
– volume: 140
  start-page: 509
  year: 2005
  ident: R24-20250221
  article-title: Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2005.03.057
– volume: 217
  start-page: 393
  year: 2003
  ident: R13-20250221
  article-title: Long-term results of transscleral cyclophotocoagulation in refractory pediatric glaucoma patients
  publication-title: Ophthalmologica
  doi: 10.1159/000073068
– volume: 42
  start-page: 525
  year: 2022
  ident: R21-20250221
  article-title: Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma
  publication-title: Int Ophthalmol
  doi: 10.1007/s10792-021-02023-5
– volume: 26
  start-page: 936
  year: 2017
  ident: R28-20250221
  article-title: Outcome of micropulse laser transscleral cyclophotocoagulation on pediatric versus adult glaucoma patients
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000000757
– volume: 24
  start-page: 91
  year: 2024
  ident: R29-20250221
  article-title: Micropulse transscleral cyclophotocoagulation (MP-CPC): efficacy endpoints for the treatment of refractory paediatric glaucoma-A retrospective case-series
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-024-03358-0
– volume: 5
  start-page: 221
  year: 2001
  ident: R17-20250221
  article-title: Endocyclophotocoagulation for management of difficult pediatric glaucomas
  publication-title: J AAPOS
  doi: 10.1067/mpa.2001.116868
– volume: 19
  start-page: e0291247
  year: 2024
  ident: R33-20250221
  article-title: Micropulse cyclophotocoagulation compared to continuous wave cyclophotocoagulation for the management of refractory pediatric glaucoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0291247
– volume: 31
  start-page: 123
  year: 2020
  ident: R3-20250221
  article-title: Contemporary management of refractory pediatric glaucoma
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0000000000000642
– volume: 109
  start-page: 316
  year: 2002
  ident: R15-20250221
  article-title: Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(01)00898-3
– volume: 29
  start-page: 385
  year: 2018
  ident: R4-20250221
  article-title: New classification system for pediatric glaucoma
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0000000000000516
– volume: 11
  start-page: 34
  year: 2007
  ident: R18-20250221
  article-title: Endoscopic diode laser cyclophotocoagulation in the management of aphakic and pseudophakic glaucoma in children
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2006.08.015
– volume: 33
  start-page: 126
  year: 2024
  ident: R34-20250221
  article-title: Comparison of efficacy of micropulse and continuous wave cyclophotocoagulation in patients with pediatric glaucoma
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000002335
– volume: 122
  start-page: 2216
  year: 2015
  ident: R7-20250221
  article-title: Long-term outcomes of trabeculectomy augmented with mitomycin C undertaken within the first 2 years of life
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2015.07.028
– volume: 59
  start-page: 165
  year: 2017
  ident: R1-20250221
  article-title: Surgical management of pediatric glaucoma
  publication-title: Dev Ophthalmol
  doi: 10.1159/000458495
– volume: 18
  start-page: 550
  year: 2014
  ident: R9-20250221
  article-title: Surgical outcomes of Baerveldt implants in pediatric glaucoma patients
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2014.08.003
SSID ssj0037198
Score 2.3660696
Snippet Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design:...
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Hospital-based...
Purpose: To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Design:...
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma. Hospital-based...
Purpose:To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory...
To analyze the safety and efficacy of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in pediatric eyes with refractory glaucoma.PURPOSETo analyze the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage S227
SubjectTerms Adolescent
Care and treatment
Child
Child, Preschool
childhood glaucoma
Ciliary Body - surgery
Development and progression
Eye
Female
Follow-Up Studies
Glaucoma
Glaucoma - physiopathology
Glaucoma - surgery
Glaucoma in children
Humans
Infant
Intraocular Pressure - physiology
Laser Coagulation - methods
Light coagulation
Male
Medical care
Methods
micropulse transscleral cyclophotocoagulation
Original
Original Article
Patient outcomes
Patients
pediatric glaucoma
Pediatrics
Prospective Studies
Quality management
refractory glaucoma
Sclera - surgery
Success
Surgery
Tonometry, Ocular
Treatment Outcome
Visual Acuity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDwgJId4ECjISAi6hiR-xcyyIVakoHEql3iyvPYEVarbq7grl3zMTJ6sND3HhkEtmVkq-GXtmNuNvGHthYh2KKMq8QXfIlfQ-t1gH5RgsqmC8jnVNZ4dPPlVHZ-r4XJ_vjPqinrBED5yAO9DVHLMAkBHjCgYba3WMEoOKKctolAXafTHmjcVU2oOlKfspuJTv58pIm0h9VFnIgw_Hn9_g5bAWqpxQk3jU0_b_vjnvRKdfOydv_ljSV-3V976pfSc0zW6zW0NOyQ_Tu9xh16C9y66fDF_N77GPp76Bdcd9GzkQZYQPHV82_GKR5netgC9afjkO7eDQwYrTH7QcH_eqH8jTcUyzN-id_j47m73_8u4oH6Yo5EEr0-VGVGau540oY9ShCFADwgKVx9xNlcFCKQRUgGUXRNvoYAJY0SgNKKu9EfIB22uXLTxi3JpQgGoqVcy1QnlN1V-wBeCG7-umyNjrEUt3mcgyEGZHsDuCfAf2jL0lrLdqxHLd30Dbu8H27l-2z9grspSjtYjmQPTSkQJ8WmK1coeW6M2woCoz9nKi-TVxev9JcX-iiIstTMWjU7hhsa-cJMIhTKO0zNjzrZh-SQ1sLSw3g44lrqGMPUw-tH13zBExD7OIiZ141wScqaRdfOupwEvM36QsbMZmE0d0F-kw5d_gd6dCGJe8z6H3udH7Hv8PuzxhNwSNSe5b9fbZ3vpqA08xd1vPn_XL9CfuVj4K
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Medknow Open Access Journals
  dbid: W3E
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSAipQrwJFGQkBFwC8St2jgV1VSoKh1KpNyuxJ7BCzVbdXVX598zksdpAuXHYS8bJZj_P2J_Xnm8Ye21jEbIoRVqjO6RalWXqcB2U4mSRB1uaWBSUO3z8NT881Udn5mwQSaJcmK39ey0y9eHz0bf3-PG4csm91DfZLWlxlqbUEXUwDrnKiq7oLdH7VFvleg2f6x4wmX46lf6_x-KtyejPg5K7VwvaxF7-6s6wb81Es3vs7kAh-X7f5_fZDWgesNvHwyb5Q_blpKxh1fKyiRxIIaIMLV_U_Hzel-taAp83_GKs0cGhhSWn_2M5vu5lV3-n5ciq1-iM5SN2Ojv4_ukwHYompMFo26ZW5rYyVS1FjCZkAQpAWCAvkappERwIKSEHXGVBdLUJNoCTtTaAtqK0Uj1mO82igaeMOxsy0HWus8potBe02AsuAxzfy6LOEvZuxNJf9NoYCLMn2D1BvgV7wj4S1ptmJGrdXcC-9kOMeJNXSPhARaQQ-FXOmRgV8gcrRLTaQcLeUk95Cj3sDkSvzyDAtyURK7_vSM0M108iYW8mLX_0Et7XNdybNMTYClPz6BR-iO2lV6QvhKzJqIS92pjpTjqv1sBiPbRxJC2UsCe9D21-O1JCpF0OMXET75qAM7U085-d8rdAuqZU5hI2mziiP-9zJ_8Fvz-R0vre-zx6nx-979n_etBzdkdSZeTudN4e21ldruEF0rVV9bIL1d-dATsX
  priority: 102
  providerName: Wolters Kluwer Health
Title Safety and efficacy of micropulse in pediatric eyes with refractory glaucoma
URI https://doi.org/10.4103/IJO.IJO_1066_24
https://www.ncbi.nlm.nih.gov/pubmed/39982084
https://www.proquest.com/docview/3169111053
https://www.proquest.com/docview/3169182283
https://pubmed.ncbi.nlm.nih.gov/PMC12013308
https://doaj.org/article/56b095e3d853415885dd3661711d748e
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVgV0JICPFNYKmMhIBLliS2Y-eEWthqWVE4LBV7s1J7slSw6dIPQf49M0laGigc2kPtNsnLc-dNbL9h7Jn2mYt8EocF0iGUIs9Dg3lQiMEidTpXPsto7_DoQ3o8lidn6ux3OaAWwMXO1I7qSY3n3w5_fq9e44BH_Xoo40i8enfy8RBfFrOb1CbyKtunIxHFR3IzpSB0XBfGpRQglFqYxudn1w90QlTt5P_3__VWwPpzMeWNHzOa6F58rde5b0Wr4S12s5WZvN_w4ja7AuUddm3UTqTfZe9P8wKWFc9Lz4FcJHJX8VnBL6ZNSa8F8GnJL9d1PDhUsOD0zJbj6c7rGj0VR-W9QsLm99h4ePTpzXHYFlYInZK6CnWS6omaFEnsvXKRgwwQFkhzlHMydgbiJIEUMBMDbwrltAOTFFIBtmW5TsR9tlfOSnjIuNEuAlmkMpooie0ZJYTORIAxIM-KKGAv11jay8Y_A2G2BLslyLdgD9iAsN50I-Pr-oPZ_Ny248iqdIKiEIRHmYGHMkZ5L1Bj6Dj2WhoI2Au6U5YIg7cD0Wt2GeDZktGV7RtyPMMcKw7Y807P88bme1fHg05HHH-u27wmhV3T1wryIEJlpUTAnm6a6Zu0pq2E2artY8h-KGAPGg5trh1lI0ozg5iYDrs64HRbyumX2h08RkknRGQCNuwQ0V40-yv_Bb89TRJtG_ZZZJ9ds-_R_6__MbueUE3kel3eAdtbzlfwBIXactJj-_3B28GwVz_o6NXDEd8_i6NfY2s9hQ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+and+efficacy+of+micropulse+in+pediatric+eyes+with+refractory+glaucoma&rft.jtitle=Indian+journal+of+ophthalmology&rft.au=Sivasubramanian%2C+Raajaraajeshwari&rft.au=Siddharth%2C+Kumar&rft.au=Senthilkumar%2C+Vijayalakshmi+A&rft.au=Mani%2C+Iswarya&rft.date=2025-03-01&rft.pub=Medknow+Publications+and+Media+Pvt.+Ltd&rft.issn=0301-4738&rft.volume=73&rft.issue=Suppl+2&rft_id=info:doi/10.4103%2FIJO.IJO_1066_24&rft.externalDocID=A828307681
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4738&client=summon